Skip to main content
. Author manuscript; available in PMC: 2017 Oct 18.
Published in final edited form as: J Am Stat Assoc. 2016 Oct 18;111(515):1075–1095. doi: 10.1080/01621459.2016.1164052

Table 1.

Covariate and outcome information for n=5,298 Medicare beneficiaries diagnosed with pancreatic cancer in the six New England states during a hospitalization between 2000–2009. Outcome information is considered with administrative censoring applied at 30 and 90 days post–discarge.

n Percent
Covariate information
  Sex Female 3,037 57.3
Male 2,261 42.7
  Age, years 65–69 727 13.7
70–74 1,052 19.9
75–79 1,226 23.1
80–84 1,129 21.3
≥ 85 1,164 20.0
  Race White 4,982 94.0
Non-white 316 6.0
  Charlson/Deyo comorbidity score ≤ 1 4,854 91.6
> 1 444 8.4
  Entry route Emergency room 2,255 42.6
Transfer from another facility 3,043 57.4
  Procedure during hospitalization Yes 1,291 24.4
No 4,007 75.6
  Length of hospitalization, days 1–7 3,170 59.8
8–14 1,465 27.7
≥ 15 663 12.5
  Discharge destination Home 1,823 34.4
Home with care 1,571 29.7
Hospice 419 7.9
SNF/ICF 1,219 23.0
Other facility 266 5.0
Outcome information with administrative censoring at 30 days
  Readmission and death 205 3.9
  Readmission and censored prior to death 853 16.1
  Death without readmission 1,257 23.7
  Censored prior to readmission or death 2,983 56.3
Outcome information with administrative censoring at 90 days
  Readmission and death 608 11.5
  Readmission and censored prior to death 930 17.6
  Death without readmission 1,912 36.1
  Censored prior to readmission or death 1,848 34.9